OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection

Bibliographic Details
Main Authors: E. Kroon, J. Ananworanich, K. Eubanks, J. Intasan, S. Pinyakorn, N. Chomont, S.R. Lewin, S. Palmer, L. Trautmann, H. Yang, N. Chomchey, N. Phanuphak, K. Cooper, P. Phanuphak, M. Souza, de
Format: Article
Language:English
Published: Elsevier 2016-07-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020310177
_version_ 1818595177494740992
author E. Kroon
J. Ananworanich
K. Eubanks
J. Intasan
S. Pinyakorn
N. Chomont
S.R. Lewin
S. Palmer
L. Trautmann
H. Yang
N. Chomchey
N. Phanuphak
K. Cooper
P. Phanuphak
M. Souza, de
author_facet E. Kroon
J. Ananworanich
K. Eubanks
J. Intasan
S. Pinyakorn
N. Chomont
S.R. Lewin
S. Palmer
L. Trautmann
H. Yang
N. Chomchey
N. Phanuphak
K. Cooper
P. Phanuphak
M. Souza, de
author_sort E. Kroon
collection DOAJ
first_indexed 2024-12-16T11:11:52Z
format Article
id doaj.art-6192abadda364ceda61926dd61fbb6b7
institution Directory Open Access Journal
issn 2055-6640
language English
last_indexed 2024-12-16T11:11:52Z
publishDate 2016-07-01
publisher Elsevier
record_format Article
series Journal of Virus Eradication
spelling doaj.art-6192abadda364ceda61926dd61fbb6b72022-12-21T22:33:42ZengElsevierJournal of Virus Eradication2055-66402016-07-01256OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infectionE. Kroon0J. Ananworanich1K. Eubanks2J. Intasan3S. Pinyakorn4N. Chomont5S.R. Lewin6S. Palmer7L. Trautmann8H. Yang9N. Chomchey10N. Phanuphak11K. Cooper12P. Phanuphak13M. Souza, de14Thai Red Cross AIDS Research Centre, SEARCH, Bangkok, ThailandThai Red Cross AIDS Research Centre, SEARCH, Bangkok, Thailand; Walter Reed Army Institute of Research, U.S. Military HIV Research Program, Bethesda, United States; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, United StatesCooper Human Systems, Cambridge, United StatesThai Red Cross AIDS Research Centre, SEARCH, Bangkok, ThailandWalter Reed Army Institute of Research, U.S. Military HIV Research Program, Bethesda, United States; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, United StatesUniversite de Montreal, CRCHUM and Department of Microbiology, Infectiology and Immunology, Montreal, CanadaUniversity of Melbourne, The Peter Doherty Institute for Infection, Melbourne, Australia; The Royal Melbourne Hospital, Melbourne, AustraliaThe University of Sydney, Sydney, Australia; The Westmead Institute for Medical Research, Sydney, AustraliaWalter Reed Army Institute of Research, U.S. Military HIV Research Program, Bethesda, United States; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, United StatesCooper Human Systems, Cambridge, United StatesThai Red Cross AIDS Research Centre, SEARCH, Bangkok, ThailandThai Red Cross AIDS Research Centre, SEARCH, Bangkok, ThailandCooper Human Systems, Cambridge, United StatesThai Red Cross AIDS Research Centre, SEARCH, Bangkok, Thailand; Thai Red Cross AIDS Research Centre, HIV-NAT, Bangkok, ThailandCooper Human Systems, Cambridge, United States; Thai Red Cross AIDS Research Centre, HIV-NAT, Bangkok, Thailandhttp://www.sciencedirect.com/science/article/pii/S2055664020310177
spellingShingle E. Kroon
J. Ananworanich
K. Eubanks
J. Intasan
S. Pinyakorn
N. Chomont
S.R. Lewin
S. Palmer
L. Trautmann
H. Yang
N. Chomchey
N. Phanuphak
K. Cooper
P. Phanuphak
M. Souza, de
OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection
Journal of Virus Eradication
title OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection
title_full OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection
title_fullStr OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection
title_full_unstemmed OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection
title_short OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection
title_sort oa3 5 lb effect of vorinostat hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating art during acute hiv infection
url http://www.sciencedirect.com/science/article/pii/S2055664020310177
work_keys_str_mv AT ekroon oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection
AT jananworanich oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection
AT keubanks oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection
AT jintasan oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection
AT spinyakorn oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection
AT nchomont oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection
AT srlewin oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection
AT spalmer oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection
AT ltrautmann oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection
AT hyang oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection
AT nchomchey oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection
AT nphanuphak oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection
AT kcooper oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection
AT pphanuphak oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection
AT msouzade oa35lbeffectofvorinostathydroxychloroquineandmaraviroccombinationtherapyonviremiafollowingtreatmentinterruptioninindividualsinitiatingartduringacutehivinfection